Table of Contents

November 01, 2012; Volume 79, Issue 11 suppl 3

New Directions in Small-Vessel Vasculitis: Anca, Target Organs, Treatment, and Beyond

• Diagnosis, ANCA testing, and disease activity

  • • Clinical features and diagnosis of small-vessel vasculitis

      Carol Langford, MD, MHS

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S3-S7;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.01
    • Controversies in ANCA testing

      Ulrich Specks, MD

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S7-S11;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.02
    • Defining disease activity and damage in patients with small-vessel vasculitis

      Peter A. Merkel, MD, MPH

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S11-S15;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.03

• Impact on individual organs

  • • Upper airway manifestations of granulomatosis with polyangiitis

      Daniel S. Alam, MD, Rahul Seth, MD, Raj Sindwani, MD, Erika A. Woodson, MD and Karthik Rajasekaran, MD

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S16-S21;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.04
    • Renal disease in small-vessel vasculitis

      Kirsten de Groot, MD

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S22-S26;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.05
    • Pulmonary disease in small-vessel vasculitis

      Thomas R. Gildea, MD, MS

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S27-S30;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.06
    • Ocular manifestations of small-vessel vasculitis

      James A. Garrity, MD

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S31-S33;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.07

• Monitoring and safety

  • • Monitoring patients with vasculitis

      Alexandra Villa-Forte, MD, MPH

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S34-S37;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.08
    • Safety issues in vasculitis: Infections and immunizations in the immunosuppressed host

      Carlos M. Isada, MD, FCCP

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S38-S45;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.09

• Treatment considerations

  • • Treating vasculitis with conventional immunosuppressive agents

      David Jayne, MD, FRCP

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S46-S49;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.10
    • Biologic agents in the treatment of granulomatosis with polyangiitis

      Ulrich Specks, MD

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S50-S53;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.11

• Historical perspective

  • • History of vasculitis: The life and work of Adolf Kussmaul

      Eric L. Matteson, MD, MPH

      • Cleveland Clinic Journal of Medicine November 2012, 79 (11 suppl 3) S54-S56;
      • DOI: https://doi.org/10.3949/ccjm.79.s3.12

PreviousNext

Back to top

In this issue

Cleveland Clinic Journal of Medicine

Vol. 79, Issue 11 suppl 3

1 Nov 2012

Table of Contents Table of Contents (PDF) Index by author

Sign up for alerts

Jump to

• Diagnosis, ANCA testing, and disease activity
• Impact on individual organs
• Monitoring and safety
• Treatment considerations
• Historical perspective

• Editor's Picks
• Most Cited
• Most Read

• What screening approach could improve early detection of ‘at-risk’ metabolic dysfunction–associated steatohepatitis in my patients?
• Sclerotic lesions in the metadiaphysis regions of the knee
• Comfort care: Creating a plan for hospitalized patients and their families
• Disseminated coccidioidomycosis masquerading as bacterial cellulitis
• Potassium-competitive acid blockers: Clinical pearls and practical insights

More...

More...